BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12482124)

  • 1. Lympho-hemopoietic malignancies in India.
    Bhutani M; Vora A; Kumar L; Kochupillai V
    Med Oncol; 2002; 19(3):141-50. PubMed ID: 12482124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence rates of leukemias, lymphomas and myelomas in Italy: geographic distribution and NHL histotypes.
    Masala G; Di Lollo S; Picoco C; Crosignani P; Demicheli V; Fontana A; Funtó I; Miligi L; Nanni O; Papucci A; Ramazzotti V; Rodella S; Stagnaro E; Tumino R; Viganó C; Vindigni C; Seniori Costantini A; Vineis P
    Int J Cancer; 1996 Oct; 68(2):156-9. PubMed ID: 8900420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
    Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of hematopoietic malignancies in a well-defined population in France.
    Carli PM; Milan C; Lorenzini JL; Guy H; Michiels R
    Oncology; 1986; 43(6):354-7. PubMed ID: 3808567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inheritance in lymphoproliferative disorders].
    Jønsson V; Olsen JH
    Ugeskr Laeger; 2006 Jun; 168(24):2361-6. PubMed ID: 16822421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pattern of haematological and lymphoreticular malignancy in Zimbabwe.
    Levy LM
    Trop Geogr Med; 1988 Apr; 40(2):109-14. PubMed ID: 3406999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
    Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
    Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Number of siblings and the risk of lymphoma, leukemia, and myeloma by histopathology.
    Altieri A; Castro F; Bermejo JL; Hemminki K
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1281-6. PubMed ID: 16835324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
    Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
    Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic and lymphoproliferative cancer among male veterans using the Veterans Administration Medical System.
    Namboodiri KK; Harris RE
    Cancer; 1991 Sep; 68(5):1123-30. PubMed ID: 1913485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Descriptive epidemiology of lymphatic malignancies in Greater Bombay.
    Yeole BB; Jussawalla DJ
    Oncol Rep; 1998; 5(3):771-7. PubMed ID: 9538191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant lymphoma--a 15-year study report.
    Dasgupta A; Mukherjee C; Ghosh RN; Sengupta J
    J Indian Med Assoc; 1993 Feb; 91(2):35-7. PubMed ID: 8501310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program.
    Abel GA; Bertrand KA; Earle CC; Laden F
    Hematol Oncol; 2010 Sep; 28(3):133-6. PubMed ID: 19866451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health databases to assess the incidence of lymphoid malignancies in Italian population].
    Borciani N; Vinceti M; Avanzini P; Ilariucci F; Mangone L; Martini M; Merlin M; Ferretti A; Frassineti M; Rodolfi R; Bergomi M
    Epidemiol Prev; 2000; 24(2):81-4. PubMed ID: 10863849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant lymphoma in Eastern India: a retrospective analysis of 455 cases according to World Health Organisation classification.
    Mondal SK; Mandal PK; Roy SD; Chattopadhyay S; Roy S; Biswas PK
    J Cancer Res Ther; 2014; 10(2):354-8. PubMed ID: 25022391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing incidence of lymphoproliferative disorders in Yorkshire.
    Jack AS; Morgan GJ; Clayden D; McNally R; Thomas J; Cartwright R
    Clin Lab Haematol; 1998 Oct; 20(5):289-95. PubMed ID: 9807676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinico-pathological profile of lymphomas in south India: a prospective rural referral hospital study of 103 cases.
    Ramani A; Kumar KA; Rao KK; Vidyasagar MS; Kundaje GN
    J Assoc Physicians India; 1991 Apr; 39(4):322-5. PubMed ID: 1844353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hodgkin's and non-Hodgkin's lymphomas.
    Hartge P; Devesa SS; Fraumeni JF
    Cancer Surv; 1994; 19-20():423-53. PubMed ID: 7534635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and imaging of hepatic involvement in malignant lymphoproliferative disease.
    Bach AG; Behrmann C; Holzhausen HJ; Spielmann RP; Surov A
    Clin Imaging; 2012; 36(5):539-46. PubMed ID: 22920359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence of leukemia and other hemoblastoses].
    Martirosov AR; Osechinskiĭ IV
    Klin Med (Mosk); 1975 Apr; 53(4):19-25. PubMed ID: 1097809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.